These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33111747)

  • 1. Vaccines for neglected and emerging diseases in Brazil by 2030: the "valley of death" and opportunities for RD&I in Vaccinology 4.0.
    Homma A; Freire MDS; Possas C
    Cad Saude Publica; 2020; 36Suppl 2(Suppl 2):e00128819. PubMed ID: 33111747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
    Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
    Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
    Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
    Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning.
    Ong E; Wong MU; Huffman A; He Y
    Front Immunol; 2020; 11():1581. PubMed ID: 32719684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covid-19 and its impact on immunization programs: reflections from Brazil.
    Matos CCSA; Barbieri CLA; Couto MT
    Rev Saude Publica; 2020; 54():114. PubMed ID: 33175028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Audio Interview: Vaccinology and Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Oct; 383(16):e109. PubMed ID: 33053301
    [No Abstract]   [Full Text] [Related]  

  • 7. Brazil: the emerging epicenter of COVID-19 pandemic.
    Neiva MB; Carvalho I; Costa Filho EDS; Barbosa-Junior F; Bernardi FA; Sanches TLM; Oliveira LL; Lima VC; Miyoshi NSB; Alves D
    Rev Soc Bras Med Trop; 2020; 53():e20200550. PubMed ID: 33111917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
    Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
    Front Immunol; 2020; 11():1880. PubMed ID: 32973779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines for neglected, emerging and re-emerging diseases.
    Madhav A; Mehrotra T; Sinha P; Mutreja A
    Semin Immunol; 2020 Aug; 50():101423. PubMed ID: 33250352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pandemic and vaccine coverage: challenges of returning to schools.
    Sato APS
    Rev Saude Publica; 2020; 54():115. PubMed ID: 33175029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccine development pipeline gears up.
    Mullard A
    Lancet; 2020 Jun; 395(10239):1751-1752. PubMed ID: 32505245
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of vaccines for SARS-CoV-2.
    Ng WH; Liu X; Mahalingam S
    F1000Res; 2020; 9():. PubMed ID: 32850116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronavirus Vaccine: Light at the End of the Tunnel.
    Ella KM; Mohan VK
    Indian Pediatr; 2020 May; 57(5):407-410. PubMed ID: 32291382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covid-19 and the race for a vaccine.
    Cueto M
    Hist Cienc Saude Manguinhos; 2020; 27(3):715-717. PubMed ID: 33111785
    [No Abstract]   [Full Text] [Related]  

  • 17. Global governance for COVID-19 vaccines.
    The Lancet
    Lancet; 2020 Jun; 395(10241):1883. PubMed ID: 32563355
    [No Abstract]   [Full Text] [Related]  

  • 18. The challenge of concomitant infections in the coronavirus disease 2019 pandemic era: Severe acute respiratory syndrome coronavirus 2 infection in a patient with chronic Chagas disease and dimorphic leprosy.
    Kurizky PS; Cerqueira SRPS; Cunha DV; Albuquerque CP; Aires RB; Mota LMHD; Gomes CM
    Rev Soc Bras Med Trop; 2020; 53():e20200504. PubMed ID: 33174962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers and challenges faced by Brazilian physiotherapists during the COVID-19 pandemic and innovative solutions: lessons learned and to be shared with other countries.
    Pegorari MS; Ohara DG; Matos AP; C R Iosimuta N; T K Ferreira V; Carolina P N Pinto A
    Physiother Theory Pract; 2020 Oct; 36(10):1069-1076. PubMed ID: 32896203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Vaccines: Status Report.
    Amanat F; Krammer F
    Immunity; 2020 Apr; 52(4):583-589. PubMed ID: 32259480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.